Franklin Resources’s NewAmsterdam Pharma NAMS Stock Holding History

Franklin Resources’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.7M	Buy	993,917 +223,757	+29%	+$7.37M	0.01%	817
2026 Q1	$24.7M	Buy	770,160 +1,040	+0.1%	+$33.9K	0.01%	906
2025 Q4	$27M	Buy	769,120 +363,295	+90%	+$13.2M	0.01%	858
2025 Q3	$11.5M	Buy	405,825 +71,613	+21%	+$1.72M	﹤0.01%	1120
2025 Q2	$6.05M	Buy	334,212 +78,300	+31%	+$1.43M	﹤0.01%	1293
2025 Q1	$5.24M	Buy	+255,912	New	+$5.69M	﹤0.01%	1329

Other funds holding NAMS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Franklin Resources's NAMS Position: Q2 2026 in Review

Franklin Resources increased its NewAmsterdam Pharma (NAMS) stake by 29% in Q2 2026, buying an estimated $7.37M and bringing the position to 993,917 shares worth $33.7M. The position accounts for 0.01% of the portfolio, ranked #817.

Franklin Resources first reported a position in NAMS in Q1 2025 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

Franklin Resources held 993,917 shares of NewAmsterdam Pharma worth $33.7M as of Q2 2026.
Franklin Resources bought 223,757 NewAmsterdam Pharma shares in Q2 2026, an estimated $7.37M.
NewAmsterdam Pharma made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #817 holding.
Franklin Resources first reported a position in NewAmsterdam Pharma in Q1 2025 and has held it in 6 quarters since.
194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.